Financials • Life Insurance
$283.55 ▲ +4.49
(+1.61%)
MKT CAP: $8.73B • VOL: 182.0K
52W L $230 52W H $327
PRI // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $3.29B | $3.09B | $2.75B |
| YoY Revenue Growth % | +6.6% | +12.4% | — |
| Gross Profit | $1.45B | $1.36B | $1.21B |
| Gross Margin % | 44.0% | 44.0% | 44.0% |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $463.5M | $555.2M | $680.4M |
| Operating Margin % | 14.1% | 18.0% | 24.8% |
| Net Income (GAAP) | $0 | $470.5M | $576.6M |
| EBITDA (Normalized) | $582.0M | $666.4M | $779.3M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $901.2M | $862.1M | $692.5M |
| Capital Expenditures (CapEx) | $148.1M | $139.0M | $123.7M |
| Free Cash Flow (FCF) | $753.1M | $723.1M | $568.8M |
| FCF Margin % | 22.9% | 23.4% | 20.7% |
| Return on Invested Capital (ROIC %) | 5.0% | 6.2% | 18.5% |
| Cash & Short-Term Equivalents | $756.2M | $687.8M | $528.0M |
| Total Debt (Short + Long Term) | $5.65B | $5.55B | $1.12B |
| Total Stockholders' Equity | $2.45B | $2.26B | $2.30B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR PRI.